HealthEquity (HQY) reported $350.73 million in revenue for the quarter ended July 2026, representing a year-over-year increase of 7.6%. EPS of $1.24 for the same period compares to $1.08 a year ago.
The reported revenue represents a surprise of +0.14% over the Zacks Consensus Estimate of $350.23 million. With the consensus EPS estimate being $1.19, the EPS surprise was +4.2%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total HSA Assets: $37.92 billion versus $37.64 billion estimated by two analysts on average. HSA Assets - HSA investments: $20.55 billion compared to the $20.01 billion average estimate based on two analysts. Total Accounts - CDBs: 7.02 million versus the two-analyst average estimate of 7.05 million. Total Accounts: 17.76 million versus the two-analyst average estimate of 17.64 million. HSA Assets - HSA cash: $17.37 billion compared to the $17.63 billion average estimate based on two analysts. Total Accounts - HSAs: 10.74 million versus 10.59 million estimated by two analysts on average. Revenue- Service: $124.44 million compared to the $121.1 million average estimate based on three analysts. The reported number represents a change of +5.6% year over year. Revenue- Custodial: $175.94 million versus the three-analyst average estimate of $177.7 million. The reported number represents a year-over-year change of +10.1%. Revenue- Interchange: $50.35 million compared to the $50.98 million average estimate based on three analysts. The reported number represents a change of +4.7% year over year.View all Key Company Metrics for HealthEquity here>>>
Shares of HealthEquity have returned +0.3% over the past month versus the Zacks S&P 500 composite's +3.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HealthEquity, Inc. (HQY): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).